Analysen von Richard Vosser
| 30.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 29.09.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.09.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 25.09.25 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 23.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 22.09.25 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 22.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 19.09.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 18.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 18.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.09.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.09.25 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 11.09.25 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 10.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 09.09.25 | Novartis Neutral | JP Morgan Chase & Co. | |
| 04.09.25 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 04.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 01.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 01.09.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.08.25 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.08.25 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 07.08.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.08.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 06.08.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.08.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 01.08.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 30.07.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.07.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 28.07.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 28.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 25.07.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 24.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 23.07.25 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 23.07.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 22.07.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 21.07.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 21.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 18.07.25 | Novartis Neutral | JP Morgan Chase & Co. | |
| 17.07.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 15.07.25 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 15.07.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 14.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 09.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 07.07.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 02.07.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 30.06.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 30.06.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 30.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |